Glibenclamide and Metformin Tablet Manufacturer, Exporter & Global Supplier

Glibenclamide and Metformin Tablet Exporter, as a reputed we ensure that our products meet international quality standards, providing reliable diabetic care solutions to patients across the globe. Glibenclamide and Metformin Tablet is a highly effective oral anti-diabetic combination medicine used for the management of type 2 diabetes mellitus. This dual therapy combines Glibenclamide, a sulfonylurea that stimulates insulin release, with Metformin, a biguanide that reduces glucose production and improves insulin sensitivity.

About Glibenclamide and Metformin Tablet

This fixed-dose combination is widely prescribed for patients who require more than one oral medicine to achieve adequate blood sugar control. Glibenclamide enhances insulin secretion, while Metformin reduces hepatic glucose production and improves peripheral glucose uptake. Together, they help maintain glycemic balance effectively. Our company, recognized as a leading Glibenclamide and Metformin Tablet Exporter, provides formulations manufactured under WHO-GMP and ISO-certified facilities, ensuring both safety and efficacy.

Key Benefits and Uses

• Helps manage blood sugar levels in type 2 diabetes patients.

• Reduces the risk of long-term diabetic complications.

• Improves insulin sensitivity and pancreatic function.

• Convenient single-tablet therapy for better patient compliance.

Being an established Glibenclamide and Metformin Tablet Exporter, we also provide customized strengths and packaging to suit market-specific demands. Our global distribution network ensures accessibility for healthcare institutions, pharmacies, and patients worldwide.

Dosage and Administration

The dosage of Glibenclamide and Metformin Tablet must be individualized according to patient needs and prescribed by a healthcare professional. Typically, it is taken once or twice daily with meals to minimize gastrointestinal side effects. As a flexible Glibenclamide and Metformin Tablet Exporter, we supply both standard and customized dosage forms to meet international requirements.

Precautions

As a responsible Glibenclamide and Metformin Tablet Exporter, we emphasize the following precautions:

• Should not be used in patients with type 1 diabetes.

• Contraindicated in individuals with severe kidney or liver impairment.

• Avoid alcohol consumption while on therapy, as it increases the risk of lactic acidosis and hypoglycemia.

• Pregnant and breastfeeding women should only use under medical supervision.

We are committed not only as a Glibenclamide and Metformin Tablet Exporter, but also as a reliable partner in patient safety and healthcare awareness.

Possible Side Effects

While generally safe, some patients may experience side effects such as:

• Hypoglycemia (low blood sugar)

• Nausea, vomiting, or diarrhea

• Stomach discomfort or metallic taste

• Weight gain in some cases

• Rare but serious risk of lactic acidosis with Metformin

By maintaining transparency, we strengthen our reputation as a trusted Glibenclamide and Metformin Tablet Exporter serving global markets.

Why Choose Us?

• WHO-GMP & ISO-certified production standards.

• Leading Glibenclamide and Metformin Tablet Exporter with a strong global supply chain.

• Expertise in bulk manufacturing, third-party, and contract manufacturing.

• Competitive pricing with assured quality and timely delivery.

As a committed Glibenclamide and Metformin Tablet Exporter, our mission is to deliver world-class diabetic medicines that are accessible, safe, and effective. Through our international presence, we continue to support healthcare providers and patients in the ongoing fight against diabetes.

Global Distribution Network

With a strong logistics and compliance framework, we successfully export Glibenclamide and Metformin Tablet to a broad range of international markets, including: Venezuela, Brazil, Cambodia, Philippines, Nigeria, Myanmar, Thailand, Singapore, Russia, Kyrgyzstan, Tajikistan, Kenya, Zimbabwe, Somalia, Djibouti, Belarus, Macedonian, And Turkey.